NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky commenced an investigation the Board of Directors of Chindex International Inc. (“Chindex” or “the Company”) (NasdaqGS:CHDX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to a consortium led by an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Roberta Lipson, the CEO of Chindex.
Click here to learn more: http://zlk.9nl.com/chindex-international-chdx, or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Chindex shareholders will receive $19.50 for each share of Chindex common stock they own. The investigation concerns whether the Chindex Board breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Lipson is taking advantage of her position to purchase the Company at an unfair price.
If you own Chindex common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/chindex-international-chdx.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.